NCT05538819View on ClinicalTrials.gov

The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure

CompletedOBSERVATIONAL
Enrollment

1,018

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

June 1, 2022

Study Completion Date

July 1, 2022

Conditions
Chronic Heart FailureType 2 DiabetesCardiovascular MortalityCohort Study
Interventions
DRUG

Glimepiride

Glimepiride 1-4 mg/day

Trial Locations (1)

430030

Tongji Hospital, Wuhan

All Listed Sponsors
collaborator

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

OTHER

lead

Dao Wen Wang

OTHER

NCT05538819 - The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure | Biotech Hunter | Biotech Hunter